Takeda Strengthens Oncology Pipeline with Elritercept through Licensing Agreement with Keros Therapeutics BWI Takeda Strengthens Oncology Pipeline with Elritercept through Licensing Agreement with Keros Therapeutics creativebharatgroup@gmail.com December 3, 2024 Osaka, Japan & Cambridge, Mass., United States: − Elritercept is a late-stage,... Read More Read more about Takeda Strengthens Oncology Pipeline with Elritercept through Licensing Agreement with Keros Therapeutics
